Tien Liang BioTech Co., Ltd.
4127
Rank in Stocks
#22801
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New... Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
Share Price
$1.08
Last synced: 2026-11-10
Market Cap
$49.52M
Change (1 day)
3.05%
Change (1 year)
7.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Tien Liang BioTech Co., Ltd. (4127)
Category
Healthcare
EPS for Tien Liang BioTech Co., Ltd. (4127)
EPS as of June 2026 TTM: $0.05
According to Tien Liang BioTech Co., Ltd.'s latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of $-0.01, a decrease compared to its 2024 EPS of $0.01.
EPS history for Tien Liang BioTech Co., Ltd. from 2019 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -566.00% |
| 2025 | $-0.01 | -188.61% |
| 2024 | $0.01 | -37.80% |
| 2023 | $0.01 | -70.05% |
| 2022 | $0.04 | 15.22% |
| 2021 | $0.04 | -191.54% |
| 2020 | $-0.04 | 17.89% |
| 2019 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | 13,851.50% |
DE
|
|
| $6.08 | 12,942.06% |
DE
|
|
| $1.55 | 3,227.47% |
JP
|
|
| $3.66 | 7,754.08% |
CH
|
|
| $0.45 | 865.67% |
IL
|
Questions about Tien Liang BioTech Co., Ltd.'s earnings per share (EPS)
What is Tien Liang BioTech Co., Ltd.'s earnings per share (EPS)?
Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) was $-0.01, compared with $0.01 in 2024.
How has Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) was highest in 2022 ($0.04) and lowest in 2020 ($-0.04).
How does Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Tien Liang BioTech Co., Ltd.'s earnings per share (EPS) ($0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.